LT - CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL
EN - CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 38/26 |
(2006.01) |
|
|
A61K 31/37 |
(2013.01) |
|
|
A61K 31/37 |
(2006.01) |
|
|
A61K 31/401 |
(2013.01) |
|
|
A61K 31/40 |
(2006.01) |
|
|
A61K 31/565 |
(2013.01) |
|
|
A61K 31/401 |
(2006.01) |
|
|
A61K 38/26 |
(2013.01) |
|
|
A61P 3/04 |
(2018.01) |
|
|
A61K 31/565 |
(2006.01) |
|
|
A61K 31/567 |
(2006.01) |
|
|
A61P 25/04 |
(2018.01) |
|
|
A61K 31/7048 |
(2006.01) |
|
|
A61P 9/00 |
(2018.01) |
|
|
A61P 3/10 |
(2006.01) |
|
|
A61P 25/00 |
(2018.01) |
|
|
A61K 31/167 |
(2013.01) |
|
|
A61P 15/18 |
(2018.01) |
|
|
A61K 31/567 |
(2013.01) |
|
|
A61K 31/40 |
(2013.01) |
|
|
A61K 31/7048 |
(2013.01) |
|
|
A61K 38/05 |
(2013.01) |
|
|
A61P 7/02 |
(2018.01) |
|
|
A61K 31/352 |
(2013.01) |
|
|
A61P 3/10 |
(2018.01) |
European patent
| (11) |
Number of the document |
3565580 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
18709116.0 |
|
Date of filing the European patent application |
2018-01-03 |
| (97) |
Date of publication of the European application |
2019-11-13 |
| (45) |
Date of publication and mention of the grant of the patent |
2024-03-06
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/US2018/012204 |
|
Date |
2018-01-03 |
PCT application publication
| (87) |
Number |
WO 2018/129058 |
|
Date |
2018-07-12 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201762441833 P |
2017-01-03
|
US |
Inventors
| (72) |
BARON, Michelle , US
YOUNG, Andrew , US
|
Grantee
| (73) |
i2o Therapeutics, Inc. ,
700 Main Street, Cambridge, MA 02139,
US
|
Title
| (54) |
CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL |
| |
CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL |
